Literature DB >> 1322325

How do eukaryotic activator proteins stimulate the rate of transcription by RNA polymerase II?

J Ham1, G Steger, M Yaniv.   

Abstract

A large number of activator proteins have now been identified in higher and lower eukaryotes, which bind to the regulatory regions of protein-encoding genes and increase the rate at which they are transcribed by RNA polymerase II. The mechanism by which activators function is being intensively studied and some of the targets of transcriptional activation domains have now been identified. These studies have also revealed novel classes of regulatory factors, which were not anticipated by extrapolating from the principles obtained with prokaryotic promoters.

Mesh:

Substances:

Year:  1992        PMID: 1322325     DOI: 10.1016/0014-5793(92)80906-w

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Structure of the gene encoding the 14.5 kDa subunit of human RNA polymerase II.

Authors:  J Acker; M Wintzerith; M Vigneron; C Kedinger
Journal:  Nucleic Acids Res       Date:  1993-11-25       Impact factor: 16.971

2.  Transcriptional repression by the human bZIP factor E4BP4: definition of a minimal repression domain.

Authors:  I G Cowell; H C Hurst
Journal:  Nucleic Acids Res       Date:  1994-01-11       Impact factor: 16.971

3.  Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein.

Authors:  A Emili; J Greenblatt; C J Ingles
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

4.  The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding.

Authors:  G Steger; J Ham; O Lefebvre; M Yaniv
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

5.  Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure.

Authors:  J Ham; G Steger; M Yaniv
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.